572
Participants
Start Date
March 31, 2004
Primary Completion Date
September 30, 2005
Study Completion Date
September 30, 2005
epoetin alfa or beta
iv 3 times weekly, as prescribed
methoxy polyethylene glycol-epoetin beta (Mircera)
60, 100 or 180 micrograms sc (starting dose) every 2 weeks
methoxy polyethylene glycol-epoetin beta (Mircera)
60, 100 or 180 micrograms sc (starting dose) every 4 weeks
Panama City
Taipei
Taichung
Budapest
Brussels
Budapest
Edegem
Hasselt
Miskolc
Debrecen
Odense
Pécs
Ghent
Bangkok
Bangkok
Berlin
Mexico City
Caen
Huddinge
Santiago de Compostela
Turku
Lecco
Cremona
Morgantown
Raleigh
Madrid
Madrid
Alcorcón
Nîmes
Venezia
Mestre
Pamplona
Tampere
Bad Hersfeld
Tours
Modena
Saint-Priest-en-Jarez
Toledo
Prato
Brooklyn Center
Thionville
Boulogne
Cuernavaca
Bayonne
Phitsanulok
Karlstad
Cabestany
Kaiserslautern
Hot Springs
Dallas
Houston
Saint-Germain-en-Laye
San Antonio
Poitiers
Limoges
Los Angeles
Riverside
Pantin
Portland
Sacramento
San Jose
Boston
Springfield
Detroit
Winston-Salem
Curitiba
São Paulo
São Paulo
Brno
Ostrava
Pilsen
HUS
Christchurch
Wellington
Durban
Gdansk
Kielce
Krakow
Wroclaw
Ponce
Barcelona
Palma de Mallorca
Belfast
Cambridge
Dundee
Exeter
Leicester
London
London
London
Hoffmann-La Roche
INDUSTRY